摘要 |
<p>Novel methods are provided for the treatment or prevention of B cell mediated conditions in a mammal that comprise administering to said mammal a therapeutically effective amount of a pharmaceutical composition comprising at least one DR6 agonist or DR6 antagonist.</p> |